GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (WBO:ZOTS) » Definitions » Sale Of Investment

Zoetis (WBO:ZOTS) Sale Of Investment

: €12 Mil (TTM As of Dec. 2023)
View and export this data going back to 2019. Start your Free Trial

Zoetis's sale of investment for the three months ended in Dec. 2023 was €-10 Mil. It means Zoetis gained €-10 Mil from selling investments. Zoetis's sale of investment for the trailing twelve months (TTM) ended in Dec. 2023 was €12 Mil.

Compared with last quarter (€19 Mil in Sep. 2023 ), Zoetis gained less money from selling investments in Dec. 2023 (€-10 Mil).


Zoetis Sale Of Investment Historical Data

The historical data trend for Zoetis's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 124.20 - 38.94 21.71 11.00

Zoetis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sale Of Investment Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -48.14 12.14 -9.23 18.74 -10.09

Zoetis Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zoetis Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Zoetis's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Zoetis (WBO:ZOTS) Business Description

Address
10 Sylvan Way, Parsippany, NJ, USA, 07054
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis (WBO:ZOTS) Headlines

No Headlines